Long Term Effects of an Early Response to Certolizumab Pegol (CZP, Cimzia®) in Rheumatoid Arthritis (RA) Patients

Clinical trial NCT01288287 · COMPLETED

Trial details

NCT number: NCT01288287
Sponsor: UCB Pharma
Status: COMPLETED
Study type: OBSERVATIONAL

Arthritis,Rheumatoid

Start date: 2011-07-01
Primary completion: 2014-10-01
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.